Close
Nordic 9Nordic 9

Walden Catalyst Ventures (investor - Venture Capital)

United States waldencatalyst.com
See something wrong or missing? Let us know
Offices:San Francisco

Walden Catalyst Ventures is an American investment company founded by Lip-Bu Tan and Young Sohn.

Average round investment:78.47M USD
Average number per year:1.0
Distribution: 2024 (1)2023 (1)2022 (1)
Portfolio companies: Netherlands Nearfield InstrumentsSwitzerland ANYboticsUnited Kingdom Peptone
Mostly invests in: Netherlands Netherlands (1) Manufacturing (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Walden Catalyst Ventures

Name Criteria
France Flexstone Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Robotics, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Hercules Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Luxembourg Luxembourg Future Fund
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Robotics, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Medicxi
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Fearless Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Evotec AG
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States National Resilience
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Concord Health Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Software Services, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Petrichor Healthcare Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top